Mylan Must Produce Blood Pressure Meds In Apotex IP Row

Law360, Los Angeles (June 4, 2013, 3:41 PM EDT) -- A Florida federal judge on Tuesday granted in part Apotex Inc.'s motion to compel discovery of Mylan Pharmaceuticals Inc.'s quinapril products in a patent infringement lawsuit over blood pressure medication development methods, ruling it is entitled to view the products if they are relevant to the case.

The Canada-based Apotex argued that the discovery is relevant to Mylan's invalidity defenses and that Mylan must produce the development documents that describe its efforts to develop the formulations. The Pennsylvania-based Mylan argued that the discovery request was too...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.